Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Safety and Efficacy of ABX-1431 in Patients With Central Pain

NCT03138421 is registered in ClinicalTrials.gov with Abide Therapeutics as lead sponsor.

NCT NCT03138421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03138421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Placebo-Controlled, Crossover Study to Evaluate the Safety and Efficacy of ABX-1431 in Patients With Central Pain
Lead sponsor
Abide Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
August 1, 2017
Completion date
July 24, 2018
Enrollment
9 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

longitudinally extensive transverse myelitis, multiple sclerosis, neuromyelitis optica spectrum disorder, transverse myelitis